Medicare Fraud Detection and Deterrence Act of 2025
- Sponsor
- Rep. Doggett, Lloyd [D-TX-37]
- Committees
- Ways and Means Committee (primary)
- Last action
- Mar 3, 2025
Bottom line
The bill aims to enhance Medicare program integrity and reduce fraud by improving provider identification, data transparency in Medicare Advantage, and oversight of telehealth services.
What it actually does
This bill strengthens health care waste, fraud, and abuse provisions within the Social Security Act, primarily targeting Medicare. It mandates the deactivation of National Provider Identifiers (NPIs) for individuals and certain entities excluded from Federal health care programs, requires Medicare Advantage plans to include ordering/referring provider NPIs in encounter data for specific services, and establishes a claims modifier to identify telehealth services furnished by providers with relationships to primarily telehealth-focused companies.
Proponents argue
Supporters argue that these measures are crucial for protecting taxpayer dollars by closing loopholes that allow fraudulent actors to continue operating or billing federal programs. They contend that increased transparency and stricter enforcement mechanisms will deter waste, fraud, and abuse, ultimately strengthening the financial solvency of Medicare and ensuring appropriate use of healthcare funds.
Opponents contend
Critics might raise concerns about the potential for increased administrative burden on healthcare providers, Medicare Advantage plans, and telehealth companies, which could lead to higher operational costs or delays in service provision. Some may also argue that certain provisions, particularly those related to telehealth, could inadvertently stifle innovation or limit access to care by imposing overly complex compliance requirements.
The bill is concise and easily digestible, allowing for quick comprehension of its provisions and their immediate implications.
Section 2(a)
Mandatory NPI Deactivation for Excluded Entities
This provision requires the Secretary of Health and Human Services to revise standards to deactivate the National Provider Identifier (NPI) of any individual excluded from participation in Federal health care programs. For organizational entities, NPI deactivation can occur upon request from the Inspector General of the Department of Health and Human Services. The deactivation period aligns with the exclusion period, and an annual review is mandated to ensure compliance.
Supporters argue
Supporters argue this closes a critical loophole, preventing excluded individuals and entities from continuing to operate or bill using their NPIs, thereby enhancing program integrity and significantly reducing opportunities for fraud and abuse within federal healthcare programs.
Critics contend
Critics might argue that while the intent is valid, the administrative process for deactivation and reactivation could be cumbersome, potentially leading to delays or errors that unfairly impact providers, though direct opposition to this specific anti-fraud measure is generally limited.
Tradeoffs
The tension lies between robust fraud prevention through NPI deactivation and ensuring efficient administrative processes for providers, particularly regarding timely reactivation upon exclusion termination to avoid undue disruption.
Section 2(b)
NPI Requirement for Medicare Advantage Encounter Data
This section mandates that Medicare Advantage (MA) plans include the National Provider Identifier (NPI) of the ordering or referring provider for specific 'designated items or services' in their encounter data submitted to the Secretary. Designated items include durable medical equipment, prosthetic/orthotic devices, clinical diagnostic laboratory tests, diagnostic imaging tests, and home health services. Encounter data will be rejected if the required NPI is missing or invalid.
Section 2(c)
Telehealth Service Modifier for Company Relationships
This provision requires the Secretary to establish a new claims modifier for telehealth services. This modifier must be included on claims for telehealth services furnished by a physician or practitioner who has an employment or contractual relationship with a 'telehealth company.' A telehealth company is defined as an entity that primarily furnishes telehealth services and does not (or only de minimis) furnish in-person services. Payment for such services will be denied if the modifier is not included.
The definition of a 'telehealth company' includes an entity that 'does not employ or otherwise contract with any physician or practitioner to furnish items and services in-person (or that employs or otherwise contracts with physicians or practitioners to furnish such in-person items and services in a de minimis manner compared to the amount of telehealth services furnished by such physicians or practitioners, as specified by the Secretary).'
Section 1834(m)(10)(C)(ii)(II) of the Social Security Act, as added by Section 2(c) of the bill
Why it matters:Delegating the definition of 'de minimis' to the Secretary is standard legislative practice for technical details, allowing for flexibility and adaptation. However, it means the practical impact of the telehealth provision will be largely determined by future agency regulations, not explicitly by the bill text.
Case for: Proponents argue that delegating the 'de minimis' definition to the Secretary allows for flexibility to adapt to evolving telehealth practices and ensures the rule can be implemented effectively without being overly prescriptive in statute, accommodating future changes in the industry.
Case against: Critics might contend that leaving such a crucial definition to agency discretion creates uncertainty for telehealth companies and providers, potentially leading to future regulatory changes that could significantly alter business operations without direct Congressional input or a clear legislative framework.
Estimated impact: The Secretary's definition of 'de minimis' will directly determine which telehealth companies and their associated providers are subject to the new claims modifier, significantly influencing the scope and impact of the telehealth transparency provision on the industry.